论文信息 - Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors. - 字舞流文

Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors.

S. Kaye | A. Schuh | M. Hall | S. Dutton | C. Gourley | R. Wharton | S. Nicum | A. Montes | L. Boyle | R. Midgley | P. Julier | M. C. Grp | Sarah R Pearson | C. Brooks